QbD Approach Method Development for Estimation of Dabigatran Etexilate along with Its Impurities and Identification of Degradants in Capsule Dosage Form-Reference-Cited by-同舟云学术

QbD Approach Method Development for Estimation of Dabigatran Etexilate along with Its Impurities and Identification of Degradants in Capsule Dosage Form

Published:2016 Issue:06 Volume:07 Page:494-524
ISSN:2156-8251
Container-title:American Journal of Analytical Chemistry
language:
Short-container-title:AJAC

Author:

Bapatu Hanimi Reddy,Maram Ravi Kumar,Cho Woo Hyung,Pasagadugula Venkat Bhaskar Rao

Publisher

Scientific Research Publishing, Inc.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development, evaluation of critical method variables and stability assessment using a Box–Behnken design for the determination of organic impurities in a pharmaceutical dosage form of a centrally acting muscle relaxant drug chlorzoxazone;Biomedical Chromatography;2024-09-04

2. Box-Behnken design in optimization of the green liquid chromatographic method for the quantification of Afatinib in drug product: AQbD approach;Journal of Liquid Chromatography & Related Technologies;2024-07-29

3. Structural Elucidation of Novel Degradation Impurities of Ibrutinib in Ibrutinib Tablets Using Preparative Chromatography, LCMS, HRMS and 2D NMR Techniques;Journal of Chromatographic Science;2024-02-09

4. Using the AQbD Approach, Development and Validation of a Simple, Rapid Stability Indicating Chromatographic Method for Quantification of Related Impurities of Apixaban;Journal of Chromatographic Science;2023-08-17

5. A comprehensive review on QbD driven analytical procedures developed for the analysis of various drugs;Journal of Liquid Chromatography & Related Technologies;2023-03-16